BIOTECanada is pleased to announce the launch of Bio+ech Connec+, a unique forum for early-stage Canadian biotech companies to connect directly with the business development and investment leaders of multinational pharma/biotech companies.
Bio+ech Connec+ featuring Pfizer will take place on Tuesday, November 9th at 11:00 AM (ET)
This virtual forum will include a plenary session led by senior Pfizer representatives who will provide an overview of the company, its R&D priorities including its pipeline and corresponding investment priorities for the period ahead. Pfizer representatives will then engage in a question-and-answer session following the plenary and Q&A session a select group of early-stage companies will be provided an opportunity to connect bilaterally with the Pfizer representatives.